Skip to main content
NIH funding notice RFA-HG-24-004

ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)

Closed on July 28, 2024.

Posted
May 10, 2024
Close date
July 28, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,376,599 in first-year total cost, median $3,188,300.

Most frequent study sections

  1. Special Emphasis Panel[ZHG1 HGR-W (J3)]2

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under RFA-HG-24-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025PRISM: Ethically-guided multimodal AI models for predicting disease pathogenesis in individuals with pathogenic variants1UG3HG014379-01KARCZEWSKI, KONRADTATONETTI, NICHOLAS PMASSACHUSETTS GENERAL HOSPITAL, MA$3,203,253ZHG1
2025Patient centered prediction of clinically important outcomes arising from pathogenic variants1UG3HG014376-01BASTARACHE, LISARUDERFER, DOUGLASVANDERBILT UNIVERSITY MEDICAL CENTER, TN$3,173,346ZHG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.